OTX-14-003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery

NCT02089113 ↗

Phase 3 Completed 241 enrolled Ocular Therapeutix, Inc.

RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of the study was to evaluate the safety and efficacy of OTX-DP (dexamethasone insert) 0.4 mg for intracanalicular use when placed in the canaliculus of the eyelid for the treatment of post-surgical inflammation and pain in subjects who had undergone cataract extraction with intraocular lens implantation

Timeline

Start: 2014-04
Primary completion: 2015-01
Completion: 2015-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Dexamethasone	Small molecule	0.4 mg	Other

Indications

No indication recorded.